| Prev Close | 12.42 |
| Day Low/High | 12.10 / 12.66 |
| 52 Wk Low/High | 5.04 / 23.88 |
| Avg Volume | 5.55M |
Rite Aid Corp. (RAD)
12.42
NYSE : Retail Trade
| Exchange | NYSE |
| Shares Outstanding | 54.70M |
| Market Cap | 679.43M |
| EPS | -8.50 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Rite Aid Charts Send Wrong Signals to Investors Who Hope for a Recovery
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.
Adobe's Partnerships, Smart Buys Are Paying Off for Shareholders
Adobe may be eyeing future M&A.
Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.
Walgreens Stock Falls After Earnings, Guidance Disappoint
Walgreens weak guidance is sending shares plummeting on Tuesday.
Supermarket Sweepstakes
CNBC is reporting that Kroger and Walgreens Boots Alliance are "exploring a partnership to offer customers a new service that allows them to pick up groceries ordered online at Kroger at certain Walgreens locations..." Yes this signals that more ch...
Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'
Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.
Will Rite Aid End Up Like Blockbuster?
After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.
Jim Cramer on Roku, Rite Aid, Sonos, Amazon and Goldman Sachs
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's stocks from the floor of the New York Stock Exchange.
Reaction to the Failure of the Rite Aid, Albertsons Deal Is Not Positive
RAD suffers not only from concerns that Amazon is taking business but it has no growth and is barely breaking even.
Jim Cramer: Rite Aid Doesn't Have the Balance Sheet to Be Independent
They pulled the plus on the Rite Aid-Alberstons merger ahead of the vote -- listen to Cramer react to that now!
Rite Aid Traders Had It Right
The charts of Rite Aid have been stalled for months leading up to the Albertsons' merger falling through.
Here's What You Need to Know on Thursday
Let's go over the market on Thursday.
Amazon's Acquisition of PillPack is Harming Traditional Pharmacies
Amazon's acquisition of PillPack is hitting traditional pharmacies.
Facebook Reverses Crypto Ban and 4 Other Stories to Watch Wednesday Morning
These are the stories to watch as stock futures fall Wednesday morning.
Jim Cramer: Sprint/T-Mobile Merger Is Crazy ... But Just Might Work
If anyone can sell it to antitrust regulators, T-Mobile CEO John Legere can.
Speak Softly and Own These Defense Stocks: Market Recon
The world remains dangerous, and dangerous toys are not just simply in demand -- demand is increasing rapidly.
5 Things You Must Know Before Thursday's Opening Bell
Here's what you need to know today: U.S. stock futures rise modestly; Delta Air Lines and BlackRock report earnings; Facebook's value soars during Mark Zuckerberg's congressional testimony; and more. Watch now!
Second Quarter Predictions
Better-than-expected earnings will help soothe market jitters in the second quarter.
Women's History Month: Nancy Lieberman -- Still Law Firm's Youngest Partner Ever
For Women's History Month, Alpha Rising sat down with Nancy Lieberman, Of Counsel at Skadden, Arps. She was and still is the youngest person to ever make partner at her firm. She has worked on some of the biggest M&A deals in history -- and we should mention -- she's in a wheelchair and barely as use of her hands. Feel like a slacker yet? Good. Watch.
Inside Albertsons' Humble Beginnings: Video
As Albertsons prepares to bring a significant piece of Rite Aid into its family, we took a look back at how the grocer became the mega chain it is today.
Blame Amazon for Walmart's Surprising 2018 Outlook
Walmart surprised many on Wall Street with its 2018 outlook, and not positively. Here's what's up.
Elon Musk's Hyperloop and Everything You Need to Know Before You Trade Tuesday
Welcome back from the long weekend, Wall Street. Here's what you must know.
10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
The January Effect Could Push Up Some Stock Prices
Enjoy the cold snap, it may help you get things done in the markets.
The 5 Best 'Dividend Aristocrats' for 2018
The best high-yielding blue chips at discounted prices.
Let the Good Times Roll as Tech Giants Hit All-Time Highs: LIVE MARKETS BLOG
Amazon, Microsoft and Alphabet all reached all-time highs Friday.
Watch: Jim Cramer Thinks Regulators Would Approve a CVS-Aetna Deal
Amid reports that CVS Health is in discussions to purchase health insurance giant Aetna for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal.
Closing Bell: LIVE MARKETS BLOG
The Nasdaq was the lone index to close in the red Thursday.
